IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today ...

The manufacturer of AV-101, an investigational, oral nonopioid, NMDA-targeting therapy to treat neuropathic pain, announced that it has received a U.S. patent for the treatment. AV-101 (4-Cl-KYN) is ...

The facility, also known as heavy ion medical accelerator or carbon ion therapy system, is developed and maintained by the Institute of Modern Physics under the Chinese Academy of Sciences (CAS) and a ...

Louvain-La-Neuve, Belgium, and Paris, France, 7 February 2025 - Framatome, an international leader in nuclear energy committed to developi ...

A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...

Louvain-La-Neuve, Belgium, and Paris, France, 7 February 2025 - Framatome, an international leader in nuclear energy committed to developing products and services for the healthcare industry, and IBA ...

Sensorion's gene therapy for otoferlin-related hearing loss – a congenital form of deafness – has shown early signs of improving hearing in two toddlers treated in a phase 1/2 trial.

Zion Wood, a young boy from Mahwah living with severe autism, recently experienced a dream trip to the Central Florida theme ...

The pharmaceutical company plans to cut $2 billion in annual expenses by the end of 2027 through “operational efficiencies ...

A recent report from Stifel showed that 30% of licensing deals from big pharma companies now involve a Chinese biotech.

Discover how and why natural disasters like the LA fires trigger deep distress and learn practical steps to protect yourself ...

On Wednesday, officials said the remains of all 67 victims from a midair collision involving American Airlines Flight 5342 ...